Medscape
MADRID — Metformin is taken every day by more than 200 million people worldwide. Its value as a glucose-lowering agent has been established for decades. But does metformin hold similar promise for reducing rates of cardiovascular disease (CVD)? This question was the focus of a thought-provoking presentation by Simon Griffin…
Read More
Does Metformin Therapy Impact CVD in T2D? It’s Complicated
Rebecka Latson
09:20
MADRID — Metformin is taken every day by more than 200 million people worldwide. Its value as a glucose-lowering agent has been established for decades. But does metformin hold similar promise for reducing rates of cardiovascular disease (CVD)? This question was the focus of a thought-provoking presentation by Simon Griffin…
